These vaccines work by inserting a recipe into the body — the mRNA strand — that teaches cells to build a piece of the targeted virus that the body’s immune system gears up to attack.

First, pAurora2 releases the blockade of translation of the target gene on the mRNA strand, and second, the system suppresses ...

A German study published in July 2024 did not find that mRNA COVID-19 vaccines damaged children’s immune systems, contrary to posts shared online suggesting the study found signs of an immune ...

The red represents an mRNA strand. Photo credit: www.cancer.gov Primrose Bio, a San Diego biotechnology company that aims to improve the manufacture of next-generation therapeutics, has begun a ...

The genome inside each of our cells is modelled by tension and torsion -- due in part to the activity of proteins that compact, loop, wrap and untwist DNA -- but scientists know little about how those ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.

The increasingly dynamic and multifaceted landscape of mRNA therapeutics is posing new regulatory and manufacturing challenges. Both startups and established biopharma companies require innovative ...

After an initial defeat against the biggest barrier to mRNA flu vaccines—namely, B strains of influenza—GSK has returned with a reformulated candidate that has delivered the goods in the all ...

Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story.

New study uncovers a higher prevalence of heart scarring in young males after COVID-19 mRNA vaccination, raising concerns about long-term outcomes despite mild initial symptoms of vaccine ...

The investigational mRNA cancer immunotherapy is targeted for patients with lung cancer, melanoma and other solid tumours. Nineteen patients with advanced stage cancers received between one and ...